Combination unifies footprint of connected ITS systems under common software platform with unparalleled access to millions of datapoints on roadways BROWN DEER, Wis., March 25, 2026 (GLOBE NEWSWIRE) — Traffic and Parking Control Co., LLC (TAPCO), a leading provider of intelligent transportation systems (ITS) and traffic safety products announced the acquisition of MS2 (Midwestern Software Solutions), a leader in transportation data management software and analytics with a large traffic count database in North America. Over the last 20 years, MS2 has established itself as the premier provider of traffic count data and analytics software with its cloud-based solutions relied upon by more than 250 public sector agencies, including more than half of the U.S. State Departments of Transportation (DOTs). MS2’s modular software platform...

Accelerated Wealth Partners will make a strategic investment in RIA Advisors to allow the firm to scale rapidly while strictly preserving its unique culture and high-touch service model. NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) — Accelerated Wealth Partners (“AWP”), a specialized investment firm focused on scaling high-performing Registered Investment Advisors, today announced a strategic investment in RIA Advisors, a premier independent wealth management firm based in Houston, Texas. This partnership is designed to transform RIA Advisors into the preeminent destination for high-net-worth families across the state of Texas. RIA Advisors has established a formidable organic growth engine driven by the thought leadership and robust online presence of its four partners: Connie Mack, Lance Roberts, Richard Rosso, and Danny Ratliff....

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today issued the following statement in response to recent media speculation concerning intentions for a potential public take-over. Nanobiotix states that, to the best of its knowledge, there is no such intention to acquire control of the Company, and no process or assessment is being conducted toward that end. Additionally, the Company has identified factual inaccuracies in this media report which are not consistent with the Company’s most recent public disclosures. About NANOBIOTIX Nanobiotix is a late-stage clinical biotechnology...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Just Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position disclosure,...

NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced hedging its decentralized finance (DeFi) portfolio with investment in Gold. The Company has also reduced its hedge on emerging markets. Michael Young, Director of SRx Health, commented, “We are looking forward to the closing of EMJX in the near future.” Additional Information and Where to Find It In connection with the proposed transaction between the Company and EMJX intends to file with the SEC a Registration Statement on Form S-4 (the “Registration Statement”) to register the common stock to...

IBG Acquires 51% stake in BlockFuel Energy as business combination nears completion Once complete, the combined entity will become a rising oil producer and power generation company with near-term production and scalable growth strategy SYDNEY, March 25, 2026 (GLOBE NEWSWIRE) — Innovation Beverage Group Ltd (“IBG” or the “Company”) (Nasdaq: IBG), an innovative developer, manufacturer, and marketer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands, today announced that it has acquired a controlling interest in BlockFuel Energy Inc. (“BFE”), a Texas-based energy corporation. This transaction represents a significant milestone towards the proposed merger between both companies, which they anticipate closing in the coming weeks. On March 16, 2026, IBG entered into a Share Exchange Agreement...

Expands CMG’s capabilities to probabilistic subsurface risk and resource assessment CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) today announces that it has acquired Rose Subsurface Assessment (“Rose”), a globally recognized provider of probabilistic subsurface risk analysis and resource assessment software, training, consulting, and operator consortium services for the global exploration and production industry. Key Acquisition HighlightsPurchase consideration USD $9.8 million, consisting of USD $8.8 million paid in cash at closing, plus an amount equivalent to Rose’s cash on hand immediately prior to closing, with the remainder subject to a customary holdback, and a potential earn‑out of up to USD $2.5 million tied to performance milestones Trailing twelve-month...

Terns’ lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for certain patients with CML Merck to hold investor call at 8 a.m. EDT today RAHWAY, N.J. and FOSTER CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Terns for $53.00 per share in cash for an approximate equity value of $6.7 billion. This equates to approximately $5.7 billion net of acquired cash and represents an approximate premium of 31% to the 60-day and 42% to the 90-day volume-weighted average stock...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Alternative Income REIT plc(c)        Name of the party to the offer with which exempt principal trader is connected: Alternative Income REIT plc(d)        Date dealing undertaken: 24 March 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases...